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Abstract: (1) Background: Little is known about the interlinkages between dietary and plasma
non-enzymatic antioxidant capacity (D-NEAC and P-NEAC, respectively) and the body’s antioxidant
and inflammation response. Our aim was to explore these associations in 210 participants from two
Spanish European Prospective Investigation into Cancer and Nutrition (EPIC) centers. (2) Methods:
D-NEAC was estimated using published NEAC values in food. P-NEAC and total polyphenols
(TP) were quantified by FRAP (ferric-reducing antioxidant power), TRAP (total radical-trapping
antioxidant parameter), TEAC-ABTS (trolox equivalent antioxidant capacity-Azino Bis Thiazoline
Sulfonic), ORAC (oxygen radical absorbance capacity) and Folin–Ciocalteu assays. Nutrient antioxidants
(carotenes, α-tocopherol, ascorbic acid, retinol, uric acid, Q9 and Q10 coenzymes) and inflammation
markers (IL-6, IL-8, CRP, TNF-α, PAI-I, resistin and adiponectin) were also analyzed. Spearman correlation
and linear regression analyses were performed in association analyses. Analyses were stratified by
covariates and groups were defined using cluster analysis. (3) Results: P-FRAP was correlated with
D-NEAC, and significantly associated with P-NEAC in multivariate adjusted models. P-FRAP levels
were also significantly associated with plasma antioxidants (log2 scale: TP β = 0.26; ascorbic acid
β = 0.03; retinol β = 0.08; α-tocopherol β = 0.05; carotenes β = 0.02; Q10 β = 0.06; uric acid β = 0.25),
though not with inflammation-related biomarkers. Different profiles of individuals with varying levels
of P-NEAC and biomarkers were found. (4) Conclusions: P-NEAC levels were to some extent associated
with D-NEAC and plasma antioxidants, yet not associated with inflammation response.
Keywords: total antioxidant capacity; dietary antioxidants; antioxidant status; oxidative stress;
inflammatory markers
Antioxidants 2020, 9, 301; doi:10.3390/antiox9040301 www.mdpi.com/journal/antioxidants
Antioxidants 2020, 9, 301 2 of 17
1. Introduction
An increased production of free radicals and reactive oxygen species (ROS) arise from a variety
of sources (endogenous metabolic reactions and exogenous factors, e.g., pollution, smoke or UV
irradiation), but living organisms have developed protection mechanisms against oxidative stress
(OS) [1,2]. The main mechanism comprises the endogenous enzymatic antioxidant system, but dietary
non-enzymatic antioxidants are essential to counteract this process as well. Fruits and vegetables
are the main sources of dietary antioxidants including vitamin C, vitamin E and carotenoids [1].
These compounds protect cells from free radical-induced oxidative damage [2–4], thereby contributing
to reducing the risk of several non-communicable chronic diseases and aging.
Non-enzymatic antioxidant capacity (NEAC) accounts for the cumulative antioxidant capacity of
all the antioxidants contained in foods or body fluids, reflecting antioxidant activity and synergistic
interactions between these compounds [5]. NEAC is therefore regarded as a global measure of
non-enzymatic antioxidant efficiency [6,7]. The main NEAC assays are oxygen radical absorbance
capacity (ORAC), total radical-trapping antioxidant parameter (TRAP), trolox equivalent antioxidant
capacity-Azino Bis Thiazoline Sulfonic (TEAC-ABTS) and ferric-reducing antioxidant power (FRAP) [5].
Whether plasma NEAC (P-NEAC) or dietary NEAC (D-NEAC) is associated with antioxidant levels
in the blood—and in turn with inflammatory markers—is still unknown. This association might depend
on how dietary antioxidants interact with each other, and on how they are absorbed and utilized in the
body. The gut microbiome is known to modulate the metabolism of nutrient antioxidants, but whether
NEAC is affected by certain intestinal bacteria also remains obscure [8]. Little is therefore known about
the potential benefits to humans of NEAC. Several studies have analyzed correlation strengths and effect
sizes for the association between P-NEAC and inflammation markers [9–11]. These studies included
less than 100 individuals to assess these associations, with one exception [10]. Thus, these studies
may have lacked statistical power to show such associations. Nevertheless, some studies have
suggested moderate correlations between C-reactive protein (CRP) and ORAC [10], or CRP and IL-6
with FRAP [9], but not with other inflammation markers. Positive associations have been reported
between plasma ORAC and total phenolics (TP), though not with other antioxidants (e.g., α-tocopherol
and β-cryptoxanthin) [12]. Other studies also did not observe any associations between P-NEAC
and nutrient antioxidants [3,13]. As for D-NEAC, its relationship with P-NEAC has been shown
in only a few studies [3,4,14–16]. While some associations with biomarkers have been established
between D-NEAC and inflammation markers (for example, FRAP with adiponectin [17,18], TEAC with
CRP [19], and FRAP, TEAC, ORAC and TRAP with CRP [20]), most studies reported non-significant
associations (for example, neither FRAP [17], TEAC [21], nor TRAP [18] were associated with CRP
levels). Controversial findings were also reported regarding D-NEAC and nutrient antioxidant marker
associations [12,21,22].
Our aim was to explore the association between NEAC and selected nutrient antioxidants and
inflammation-related biomarkers in healthy males and females of two EPIC-Spain centers, so as to assess
the dietary and plasmatic NEAC´s potential to modulate antioxidant levels in the body, along with the
associated inflammation response. The study of such relations is essential to validate the use of dietary
and plasma NEAC in aetiological studies.




The study population comprised 210 participants of two Spanish centers of the European
Prospective Investigation into Cancer and Nutrition (EPIC) study, EPIC-Granada and EPIC-Gipuzkoa,
recruited during 1992–1996 for the EPIC-Spain study. All were healthy (mostly blood donors and
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volunteers), middle-aged subjects who agreed to participate in the study. The EPIC-Spain study
comprising EPIC-Granada, EPIC-Gipuzkoa and another three centers in Spain, was approved by the
Research Ethics Committee of the Bellvitge Hospital from Barcelona, where the EPIC-Spain coordination
center is located. More details are provided elsewhere [23].
The EPIC study´s major aim is to prospectively investigate diet and cancer associations, which
implies a long follow-up and the need for reliable exposure assessments. For the purpose of the
current study, involving a validation study of NEAC for its use in future studies, we selected
15,268 subjects from EPIC-Granada and EPIC-Gipuzkoa with blood samples and complete dietary
data after applying several exclusion criteria (Figure S1). In brief, we discarded subjects with extreme
values of energy intake, self-reported diseases at recruitment and cardiovascular disease risk factors,
use of supplements, users of drugs known to promote or alleviate oxidative stress (e.g., aspirin and
nonsteroidal anti-inflammatory drugs, among others) [24], and participants who were not at fasting
status at blood extraction (defined as more than 6 h fasting). A total of 3732 participants remained,
and 210 individuals were selected at random from this pool by stratified sampling by center. To ensure
a study sample exposed to a wide range of dietary antioxidants, not only did we consider as strata for
sampling the two Spanish centers (of geographical extremes, with varied dietary habits, from north
to south) but also quintiles of adherence to the relative Mediterranean diet score, ranging from 0 to
18 points [25]. Thus, 20 individuals were sampled from each quintile in every center (105 samples by
center). This study subsample had a sex-distribution close to the original study sample (e.g., 84% and
56% of women in EPIC-Granada and EPIC-Gipuzkoa, respectively).
2.3. Dietary Assessment and D-NEAC Estimation
Dietary data was gathered by means of a validated diet history questionnaire (DHQ) [26]. Briefly,
participants were asked about their dietary intake during a typical week over the previous year.
Information on food frequency and portion sizes, but also occasional intakes, seasonal differences
and variations between working days and weekends was collected. More than 600 food items were
introduced in the EPIC nutrient database ENDB [27].
As described elsewhere [4], for the quantification of D-NEAC the United States Department of
Agriculture (USDA) database for ORAC and for TP [28], and data of FRAP, TEAC-ABTS and TRAP
analyzed in Italian food [29,30] were used. Since coffee is known to have a very high NEAC value
due to its high content of TP, but also a poor bioavailability due to the high concentration of Maillard
products that inhibit the absorption of polyphenol metabolites [31], we estimated total D-NEAC with
and without the contribution of coffee’s NEAC. For ORAC, due to lack of information on ORAC
contained in coffee, we previously quantified ORAC in coffee brews [4].
Other variables were collected at recruitment using validated and standardized questionnaires or
protocols including lifetime history of smoking consumption, physical activity, and height, weight
and waist circumference. More information is provided elsewhere [23]. In relation to physical
activity, levels of occupational and recreational physical activity were assigned to metabolic equivalent
(METs) per hour and week, and categorized together into inactive, moderately inactive, moderately
active and active, based on cut-points determined in the EPIC physical activity validation study [32].
In addition, overall and abdominal obesity were categorized according to the WHO (normal: <25 kg/m2;
overweight: 25–30 kg/m2; obese: ≥30 kg/m2) and ATP III criteria (normal: <102 cm in men and <88 cm
in women; obese: ≥102 cm in men and ≥88 cm in women), respectively.
2.4. Blood Samples and P-NEAC Measurements
Plasma samples were stored in 0.5 mL aliquots in liquid nitrogen (−196 ◦C) since recruitment.
P-NEAC in the form of FRAP, ORAC and TEAC-ABTS was measured with different assays as previously
described [4]. Conventional methods, in essence, were applied to measure these NEAC assays [33–35].
TRAP was measured as described elsewhere [36]. ORAC without proteins was also measured [37]
Antioxidants 2020, 9, 301 4 of 17
and Folin–Ciocalteu reagent (FCR) was used to measure TP [38]. A FLUOstar Omega multimode
microplate reader (BMG Labtech) was used for the analyses and analytical characteristics [4].
2.5. Ascorbic Acid, Dehydroascorbic Acid and Total Vitamin C Determination
Plasma (50 µL) was acidified with an equal volume of 10% (w/v) meta-phosphoric acid containing
10 mmol/L of disodium-EDTA following centrifugation at 4 ◦C for 10 min at 11,200× g. The amount
of 75 µL of supernatant was stored in dark vials at −80 ◦C until analysis [39]. The quantification
was performed by ultra-high-performance liquid chromatography and mass spectrometer Acquity
UHPLC BEH system with Waters Xevo TQ-S tandem mass spectrometer (UHPLC-MS/MS) (Waters Co.,
Milford, MA, USA) and the Acquity UPLC HSS T3 column (2.1 × 100 mm, 1.8 µm). The mobile
phase consisted of water 0.1% formic acid and methanol 0.1% formic acid. Sample standards were
used. The intra-assay coefficients of variation (CV) were 4.72% for ascorbic acid and 7.36% for
dehydroascorbic acid. Inter-assay CVs were 8.65% (range: 4.77–133 µmol/L) for ascorbic acid and
9.01% (range: 0–163 µmol/L) for dehydroascorbic acid.
2.6. Fat-Soluble Antioxidant Compounds Determination
Plasma concentrations of retinol, α-tocopherol, total carotenes, CoQ9 and CoQ10 were likewise
determined by UHPLC-MS/MS Acquity and the Acquity UPLC BEH C18 1.7 µm, 2.1 × 100 mm.
Briefly, 50 µL of plasma was extracted with 150 µL of 2-propanol containing 0.0625% of BHT following
centrifugation at 4 ◦C for 10 min at 11,200× g and 150 µL of supernatant was evaporated with nitrogen and
stored in dark vials at −80 ◦C until analysis [40]. The sample was reconstituted with 150 µL 2-propanol.
The mobile phase consisted of 100% methanol 0.1% (v/v) formic acid. As above, standards were also used.
In particular, for total carotenes the standard used was β-carotene. We considered total carotenes because
β-carotene was inseparably quantified along with other carotenes in these analyses. Intra-assay CVs
were all below 5%. The inter-assay coefficients of variation (CV) were 6.77% (range: 1.34–6.28 µmol/L)
for retinol, 8.25% (range: 9.04–128 µmol/L) for α-tocopherol, 9.87% (range: 0.81–87.4 µmol/L) for total
carotenes, 9.29% (range: 0.003–0.53 µmol/L) for CoQ9 and 5.11% (range: 0.34–5.31 µmol/L) for CoQ10.
2.7. Inflammation Biomarker Measurements
All biomarkers were analyzed using Luminex 200TM System (Luminex Corporation, Austin, TX,
USA). In particular, adiponectin, plasminogen activator inhibitor-1 (PAI-1), and resistin were measured
with the Millipore’s MILLIPLEX MAP Human Adipokine Magnetic Bead Panel 1 kit. Interleukin 6 and
8 (IL-6, IL-8), and TNF-α were measured using the Millipore’s MILLIPLEX MAP Human Adipokine
Magnetic Bead Panel 2 kit. The intra-assay CVs were all below 10%. Inter-assay CVs were below 15% for
adiponectin (range: 0.03–49.9 µg/mL), PAI-I (range: 1.13–78.8 ng/mL), resistin (range: 4.97–83.4 ng/mL),
IL-6 (range: 0.01–25.4 pg/mL) and IL-8 (range: 0.24–85.6 pg/mL), and below 20% (range: 0.09–4.00 pg/mL)
for TNF-α.
CRP was measured using the MULTIGENT CRP Vario assay (CRPVa) developed and validated for
use on the Architect c16000 System (Abbott) for the quantitative immunoturbidimetric determination
of this biomarker. Plasma samples were diluted in saline solution to 1:2 dilution factor and
antigen-antibody reaction (i.e., agglutination, was detected as an absorbance change (572 nm)).
Inter-assay CVs were between 2% (0.45 mg/L values) and 0.26% (45 mg/L values).
2.8. Uric Acid Measurements
The clinical chemistry analyzer Mindray BS-200 was used to assess uric acid with a direct
colorimetric procedure [41]. Moreover, we removed the contribution of uric acid from P-NEAC levels
by subtracting the double value or uric acid from FRAP (2 is the stoichiometric factor of uric acid in the
FRAP assay [33]). The inter-assay coefficient of variation (CV) for uric acid was 12.4%.
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2.9. Statistical Analysis
The data distribution of the plasma biomarkers was tested with kurtosis, skewness and the
Shapiro–Wilk test. Since departure from normality was evidenced, log-transformed biomarker values
were used in the data analyses. The detection limit divided by two was considered to replace values
below the limit of detection if less than 10% of values were below this limit; otherwise, these values
were removed.
Spearman correlation (rho) was performed between NEAC and every biomarker.
Correlation heatmaps were derived from the correlation matrix.
Multivariate linear regression models were used to analyze the association between P-NEAC and
the selected biomarkers, whereby we used their log2 transformation to consider 2-fold increases of
the biomarkers in the models. We previously checked that the residuals were normally distributed.
Two regression models were performed for each NEAC assay, considered as the dependent variables.
In model 1, we controlled for age, sex and center. In model 2 we controlled additionally for
lifestyle factors known to affect the antioxidant potential of the diet, namely body mass index (BMI),
physical activity and smoking. Other variables, such as season at recruitment, had a negligible
impact on the results (estimates changed less than 10% comparing models with and without this
variable), and were therefore not considered for additional adjustments. The same regression models
were applied to evaluate the association between D-NEAC with the biomarkers. To account for
the influence of dietary energy intake, separate models with energy adjustment were considered.
To detect the presence of non-linear associations we applied fractional polynomials (mfp package in R).
Linear associations where thereby verified (fractional power = 1; data not shown).
Hierarchical clustering was applied considering similarity measures (e.g., distance) between each
pair of biomarkers (package heatmap in R). In particular, we created an unsupervised hierarchy of
clusters between the NEAC values and the different biomarkers upon their similarity given by a
Manhattan distance matrix [42]. This distance matrix formed the similarity measures used by the
hierarchical clustering algorithm. The two most “similar” clusters were joined at each iteration step
by the algorithm. Then, the nearest pairs of biomarkers (maximum similarity) were merged into
clusters. To calculate the similarity between two clusters, we used Ward´s method. Within the retrieved
clusters, we analyzed characteristics by covariates: center, sex, age, body fatness, physical activity and
smoking status.
We also evaluated differences between strata of these and other covariates [e.g., waist circumference
(abdominal non-obese vs. obese), season at recruitment (spring/summer vs. autumn/winter),
and adherence to the Mediterranean Diet (low/medium points vs. high) [25]] in stratified and
interaction analyses, whereby an interaction term “biomarker*covariate” was introduced in the
regression models. Models with and without the interaction term were compared with the likelihood
ratio test (LRT). We adjusted for center in random-effects models since interaction by this covariate
was evidenced (package lm4 in R).
In sensitivity analyses, we removed influential points (outliers) from the data. These points were
identified in multivariate models based on Cook´s distances [43]. We also considered FRAP without
the contribution of uric acid to asses uric-acid independent associations, and ORAC without proteins.
All analyses were performed using R 3.5.1. software version (R Core Team 2018, Austria, Vienna.
http://www.r-project.org/). Two-side tests of significance were considered and p-values < 0.05 in
hypothesis testing were considered statistically significant.
3. Results
Baseline characteristics of the study sample are shown in Table 1. The majority of the participants
were women, who were younger, more frequently non-smokers and physically inactive than men
(p-value < 0.001). In contrast, men had a higher BMI and educational attainment (p-value < 0.05) than
women. There were also significant differences by sex with regard to energy intake (p-value < 0.001)
and intake of most antioxidant nutrients and D-NEAC. By center (Table S1), there was a higher
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proportion of women in the EPIC-Granada center (p-value < 0.001), and a higher rate of non-formal
education, of people who had never smoked and of physically inactive individuals (p-value < 0.001).
Moreover, there was a significantly higher energy intake in EPIC-Gipuzkoa than in EPIC-Granada
(p-value < 0.001), possibly driven by the higher proportion of men in EPIC-Gipuzkoa. As a consequence,
significantly higher intakes of antioxidants and D-NEAC (p-value < 0.001) were observed in this center.
Significant differences by center in mean intakes of nutrient antioxidants expressed as nutrient densities
(per 1000 Kcal) were kept for most nutrients (Table S1).
Table 2 shows the median and interquartile range of the biomarkers in the study population.
Statistically significant differences (p-value < 0.001) in median levels of P-NEAC by sex were
observed for FRAP with and without uric acid, for TRAP and for ORAC without proteins. We also
observed significant sex differences for total carotenes (p-value < 0.001), adiponectin (p-value = 0.014),
PAI-I (p-value = 0.008), and resistin (p-value = 0.024). There were also statistically significant differences
by center (Table S2) regarding some biomarkers (retinol, ascorbic acid, CRP, adiponectin, PAI-I,
resistin and IL-8) and P-NEAC including uric acid (p-value < 0.001).
The heatmap of the correlation coefficients between every pair of plasmatic biomarkers is shown
in Figure 1. There was a strong correlation (rho > 0.6) between plasma FRAP and uric acid, and milder
correlations between FRAP and the other P-NEAC assays (rho > 0.3). Moderately weak correlations
were also observed between FRAP and the antioxidants (rho~0.2 to 0.3) and TRAP (rho~0.2 to 0.4),
whereas other P-NEAC assays did not seem to correlate with antioxidants despite an overall positive
trend between them. Weaker correlations were encountered between P-NEAC levels and adiponectin
and non-existent correlations with the other inflammation biomarkers. Importantly, antioxidants
were strongly correlated with each other, though less consistently with the inflammation biomarkers.
However, there seemed to be a negative trend between nutrient antioxidants and CRP or IL-8 levels
(rho~−0.1 to −0.2). Further correlations between D-NEAC and these biomarkers are shown in Table S3.
There were positive and significant correlations between dietary FRAP and corresponding levels of
plasma FRAP (rho > 0.2), and weaker correlations among the other NEAC assays. Highly significant
correlations between D-NEAC and the biomarkers were only observed for ascorbic acid (rho > 0.3).
Also, D-NEAC was positively correlated with dietary intake of nutrient antioxidants such as vitamin
C, retinol, vitamin E and β-Carotene (rho~0.2 to 0.8) (Table S4).
The association between plasma biomarkers and P-NEAC levels is shown in Table 3 for TRAP and
in Table 4 for FRAP. A positive association between plasma TRAP and other P-NEAC assays was seen
in age, sex and center-adjusted regression models (e.g., β for log2 FRAP = 0.11; p-value = 7.88 × 10−3),
though not with any of the antioxidant nutrients and inflammation biomarkers. Conversely, significant
associations were observed not only between plasma FRAP and TRAP (β for log2 TRAP = 0.15;
p-value = 7.88 × 10−3), but also with regard to TP (β for log2 = 0.26; p-value = 4.20 × 10−4), and doubling
levels (log2) of other nutrient biomarkers: ascorbic acid (β = 0.03; p-value = 2.38 × 10−2), retinol (β = 0.08;
p-value = 7.18 × 10−4), α-tocopherol (β = 0.05; p-value = 2.27 × 10−3), total carotenes (β = 0.02;
p-value =3.78× 10−2), Q10 (β = 0.06; p-value = 4.13 × 10−5), and uric acid (β= 0.25; p-value = 2.02× 10−29).
However, there were no significant associations between plasma FRAP levels and inflammation-related
biomarkers. The percentage of variance explained by any antioxidant nutrient was higher for FRAP (R2~0.3)
than TRAP (R2~0.2). For TEAC-ABTS (Table S5) and ORAC (Table S6), positive and significant associations
were observed across other NEAC assays and some (in TEAC-ABTS) or all (in ORAC) nutrient antioxidants.
Both plasma TEAC-ABTS and ORAC levels were positively associated with PAI-I (p-value = 3.96 × 10−2
and 2.26 × 10−2, respectively), while high plasma ORAC levels were also associated with decreasing IL-8
(p-value = 3.34 × 10−2) and increasing adiponectin levels (p-value = 0.05). These associations remained
in the minimally and multivariate adjusted regression models accounting for the influence of lifestyle
factors on the associations, except for IL-8 (with ORAC) and PAI-I (with TEAC-ABTS), which lost
statistical significance.
Regarding dietary TRAP and FRAP (Tables S7 and S8, respectively), the association between these
NEAC assays and the biomarkers failed to reach statistical significance in multivariate adjusted models.
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Energy intake had a negligible impact on these associations. Similar results were observed for the
other D-NEAC assays (data not shown).
Table 1. Baseline characteristics of the study sample (63 males and 147 females) within the EPIC
Granada–Gipuzkoa study.
Variables







Age 48.8 [41.4;55.2] 51.9 [46.6;57.1] 46.3 [39.9;53.1] 0.001
BMI (kg/m2) 27.2 [24.8;30.4] 28 [25.9;30.7] 26.4 [24.2;30.2] 0.042
Cigarettes/day among smokers 10.0 [5.00;20.0] 17.5 [7.00;20.0] 9.00 [3.00;12.0] 0.103
N (%) N (%) N (%)
Abdominal obesity 0.781
Normal 128 (60.9) 37 (58.7) 91 (61.9)
Obese 82 (39.1) 26 (41.3) 56 (38.1)
Center <0.001
Granada 105 (50.0) 17 (27.0) 88 (59.9)
Gipuzkoa 105 (50.0) 46 (73.0) 59 (40.1)
Smoking status
Never smoker 130 (61.9) 25 (39.7) 105 (71.4) <0.001
Former smoker 34 (16.2) 19 (30.2) 15 (10.2)
Current smoker 45 (21.4) 19 (30.2) 26 (17.7)
Physical activity
Inactive 78 (37.1) 5 (7.94) 73 (49.7) <0.001
Moderately inactive 68 (32.4) 19 (30.2) 49 (33.3)
Moderately active 41 (19.5) 24 (38.7) 17 (11.6)
Active 23 (11.0) 15 (23.8) 8 (5.44)
Education Level
None 72 (34.6) 13 (21.0) 59 (40.4) 0.088
Primary school 90 (43.3) 34 (54.8) 56 (38.4)
Secondary school 16 (7.70) 5 (8.06) 11 (7.53)
Professional 12 (5.80) 2 (3.23) 10 (6.85)








Energy intake (kcal/day) 1875 [1548;2310] 2432 [2175;2934] 1712 [1421;1999] <0.001
Fruits (g/day) 254 [139;409] 280 [142;436] 250 [139;395] 0.294
Vegetables (g/day) 206 [123;297] 211 [118;313] 206 [132;285] 0.954
Legumes (g/day) 37.2 [23.3;63.4] 48.0 [29.8;102] 35.0 [22.6;51.2] 0.001
Cereals (g/day) 202 [135;260] 261 [202;326] 173 [127;232] <0.001
Meat and meat products (g/day) 101 [69.2;148] 140 [102;163] 89.6 [65.3;120] <0.001
Fish and seafood (g/day) 54.3 [32.3;83.2] 79.7 [49.3;120] 49.3 [27.2;69.9] <0.001
Milk and dairy products (g/day) 253 [161;376] 246 [150;333] 258 [166;399] 0.232
Red wine (g/day) 0.00 [0.00;40.2] 100 [0.00;192] 0.00 [0.00;0.00] <0.001
Coffee (g/day) 84.4 [3.36;152] 98.3 [26.8;131] 76.8 [2.93;174] 0.901
Tea (g/day) 0.00 [0.00;0.00] 0.00 [0.00;0.00] 0.00 [0.00;0.00] 0.684
Flavonoids (mg/1000 Kcal/day) 161 [111;227] 170 [115;227] 157 [107;225] 0.385
β-Carotene (µg/1000 Kcal/day) 1092 [719;1574] 922 [565;1436] 1221 [836;1601] 0.005
Retinol (µg/ 1000 Kcal/day) 145 [93.8;204] 117 [88.5;183] 149 [95.8;207] 0.075
α-Tocopherol (mg/1000 Kcal/day) 5.7 [4.5;7.5] 5.2 [4.5;7] 6.1 [7.5;7.7] 0.094
Vitamin C (mg/1000 Kcal/day) 66.6 [44.8;89.5] 56.8 [40.4;71.6] 71.6 [46.3;102] <0.001
Iron (mg/1000 Kcal/day) 7.2 [6.3;8.3] 7.32 [6.67;8.34] 7.10 [6.06;8.21] 0.153
Alcohol (g/1000 Kcal/day) 0.89 [0.01;5.9] 8.67 [2.88;15.6] 0.11 [0.00;1.99] <0.001
TRAP (µmol TE/day) 8990 [3764;15,231] 10,830 [5663;16,160] 8083 [3431;14,836] 0.025
TRAP without coffee (µmol TE/day) 2771 [1876;4631] 4584 [3103;7025] 2285 [1748;3548] <0.001
FRAP (µmol Fe2+/day) 22,388 [11,079;33,821] 26,226 [17,529;36,363] 19,713 [9421;33,458] 0.009
FRAP without coffee (µmol Fe2+/day) 8765 [6560;13,636] 14,221 [10,581;17,979] 7720 [5948;11,355] <0.001
TEAC-ABTS (µmol TE/day) 6855 [3625;10,336] 8304 [5844;11,608] 6130 [3176;10,050] 0.003
TEAC-ABTS without coffee (µmol TE/day) 3083 [2321;4828] 4791 [3417;6665] 2739 [2037;4002] <0.001
ORAC (µmol TE/day) 31,501 [15,818;48,097] 33,193 [21,398;44,293] 28174 [14,444;49,880] 0.286
ORAC without coffee (µmol TE/day) 12,042 [8597;16,299] 14,300 [10,447;19,927] 11338 [8040;15,434] <0.001
Total Polyphenols without coffee (mgGAE/day) 1519 [1108;2033] 1760 [1386;2511] 1433 [1056;1938] <0.001
1 Dietary data were derived from the diet history questionnaire. Missing data: smoking status (n = 1).
2 Student’s t test and Wilcoxon’s test for continuous variables, where appropriate, and chi-square test for
categorical variables. TRAP: total radical-trapping antioxidant parameter; FRAP: ferric-reducing antioxidant
power; TEAC-ABTS: trolox equivalent antioxidant capacity—Azino Bis Thiazoline Sulfonic; ORAC: oxygen radical
absorbance capacity; TE: Trolox equivalents.
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N = 210 N = 63 N = 147
Median IQR (25–75) N Median IQR (25–75) Median IQR (25–75) p-Value 1
Ascorbic acid (µmol/L) 27.8 [20.9;46.3] 210 28.2 [23.9;54.0] 27.8 [20.4;42.7] 0.201
Dehydroascorbic acid (µmol/L) 0.00 [0.00;3.76] 210 0.00 [0.00;6.85] 0.00 [0.00;0.00] 0.007
Total vitamin C (µmol/L) 29.3 [21.4;52.5] 210 31.6 [24.3;64.3] 28.9 [20.4;44.5] 0.113
Retinol (µmol/L) 2.22 [1.85;2.73] 210 2.31 [1.94;2.81] 2.16 [1.79;2.66] 0.066
Tocopherol (µmol/L) 28.4 [21.6;37.3] 210 27.3 [20.7;37.0] 29.4 [21.7;37.5] 0.410
Carotenes (µmol/L) 3.47 [2.34;6.73] 210 2.79 [1.80;4.27] 3.92 [2.62;7.65] <0.001
Q9 (µmol/L) 0.05 [0.03;0.08] 210 0.05 [0.03;0.09] 0.05 [0.03;0.07] 0.727
Q10 (µmol/L) 1.16 [0.96;1.50] 210 1.17 [1.00;1.59] 1.15 [0.95;1.50] 0.662
Uric acid (mg/dl) 3.73 [3.05;4.48] 210 4.71 [3.96;5.41] 3.45 [2.92;4.03] <0.001
FRAP (µmol TE/L) 457 [403;519] 210 528 [471;560] 428 [393;476] <0.001
FRAP (µmol Fe2+/L) 881 [808;982] 210 996 [910;1079] 853 [785;924] <0.001
FRAP without uric ccid (µmol TE/L) 314 [267;355] 210 345 [312;387] 296 [257;341] <0.001
FRAP without uric acid (µmol Fe2+/L) 634 [574;699] 210 692 [630;754] 616 [556;678] <0.001
TRAP (µmol TE/L) 976 [884;1073] 210 1034 [907;1116] 949 [867;1047] 0.001
TEAC-ABTS (µmol TE/L) 3041 [2599;3677] 210 3115 [2508;3823] 3008 [2647;3384] 0.642
Total polyphenols (mg GAE/L) 1207 [1128;1276] 210 1206 [1126;1270] 1207 [1132;1277] 0.850
ORAC without proteins (µmol TE/L) 1160 [946;1399] 210 1308 [1098;1555] 1124 [908;1358] <0.001
ORAC (µmol TE/L) 14,706 [12,739;17,005] 210 15,138 [13,185;17,622] 14,547 [12,617;16,648] 0.173
CRP (mg/L) 1.26 [0.76;2.38] 207 1.18 [0.76;2.15] 1.32 [0.76;2.50] 0.299
Adiponectin (µg/mL) 0.10 [0.07;0.15] 207 0,08 [0.06;0.11] 0.10 [0.07;0.17] 0.014
PAI-I (ng/mL) 20.0 [14.6;27.0] 210 22.9 [17.9;29.8] 19.4 [14.3;25.2] 0.008
Resistin (ng/mL) 14.2 [11.5;18.2] 210 13.3 [10.5;16.1] 14.4 [12.0;18.8] 0.024
TNF-α (pg/mL) 0.75 [0.58;1.00] 162 0.77 [0.62;1.06] 0.74 [0.51;0.98] 0.323
IL-8 (pg/mL) 1.08 [0.68;1.70] 146 1.09 [0.68;1.68] 1.06 [0.69;1.71] 0.850
IL-6 (pg/mL) 0.69 [0.69;0.69] 210 0.69 [0.69;0.69] 0.69 [0.69;0.69] 0.776
IQR = P25–P75 1 Wilcoxon’s test for continuous variables. CRP: C-reactive protein; PAI-I: Plasminogen activator
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Abbreviations: WO = without; UA = uric acid; OS = oxidative stress.
Figure 1. Correlation matrix between biomarkers depicted as a heatmap. (Heat map represents
the color-coded correlation factors between all biomarkers including levels of P-NEAC, nutrient
antioxidants and biomarkers of inflammation in the EPIC Granada-Gipuzkoa study. The color value of
the cells is proportional to the strength of the associations, ranging from red (positive correlations) to
blue (negative correlations). The strength of the correlation is indicated in the color scale (at the right of
the panel). Pair-wise spearman correlation coefficients (rho) are shown in every cell. Abbreviations:
WO = without; UA = uric acid; OS = oxidative stress.
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Table 3. Association between P-NEAC as TRAP and the nutrient/inflammation biomarkers in the EPIC Granada–Gipuzkoa cohort sub-sample (n = 210).
Biomarkers
Model 1 Model 2
β Coefficient CI 95% p-Value R2 β Coefficient CI 95% p-Value R2
Ascorbic acid (µmol/L) −0.018 −0.038 0.002 8.47 × 10−2 0.199 −0.020 −0.040 0.001 6.16 × 10−2 0.219
Dehydroascorbic acid (µmol/L) 0.000 −0.001 0.001 9.33 × 10−1 0.187 0.000 −0.001 0.001 9.71 × 10−1 0.205
Total vitamin C (µmol/L) −0.011 −0.029 0.007 2.22 × 10−1 0.193 −0.013 −0.031 0.006 1.70 × 10−1 0.212
Retinol (µmol/L) −0.010 −0.051 0.031 6.30 × 10−1 0.188 −0.009 −0.051 0.033 6.68 × 10−1 0.206
α-Tocopherol (µmol/L) −0.013 −0.041 0.015 3.68 × 10−1 0.190 −0.015 −0.043 0.014 3.17 × 10−1 0.209
Carotenes (µmol/L) −0.002 −0.016 0.012 8.23 × 10−1 0.187 −0.003 −0.017 0.012 6.90 × 10−1 0.206
Q9 (µmol/L) −0.010 −0.024 0.004 1.80 × 10−1 0.194 −0.011 −0.026 0.003 1.27 × 10−1 0.214
Q10 (µmol/L) −0.001 −0.027 0.025 9.55 × 10−1 0.187 −0.002 −0.029 0.025 9.1 × 10−1 0.205
Uric acid (mg/dl) 0.042 0.000 0.084 5.33 × 10−2 0.202 0.046 0.000 0.091 5.03 × 10−2 0.220
FRAP (µmol TE/L) 0.164 0.091 0.238 1.86 × 10−5 0.257 0.166 0.090 0.243 3.25 × 10−5 0.271
FRAP (µmol Fe2+/L) 0.110 0.030 0.190 7.88 × 10−3 0.215 0.102 0.019 0.186 1.73 × 10−2 0.227
FRAP without uric ccid (µmol TE/L) 0.143 0.079 0.207 1.84 × 10−5 0.257 0.139 0.074 0.205 4.54 × 10−5 0.269
FRAP without uric acid (µmol Fe2+/L) 0.083 0.010 0.155 2.59 × 10−2 0.206 0.072 −0.002 0.147 5.85 × 10−2 0.219
TEAC-ABTS (µmol TE/L) 0.046 0.003 0.088 3.80 × 10−2 0.204 0.051 0.007 0.094 2.49 × 10−2 0.225
Total polyphenols (mg GAE/L) 0.144 0.018 0.269 2.58 × 10−2 0.206 0.146 0.012 0.280 3.45 × 10−2 0.223
ORAC without proteins (µmol TE/L) 0.033 −0.008 0.075 1.18 × 10−1 0.197 0.039 −0.004 0.081 7.78 × 10−2 0.217
ORAC (µmol TE/L) 0.077 0.021 0.133 7.45 × 10−3 0.215 0.079 0.022 0.135 7.29 × 10−3 0.233
CRP (mg/L) −0.004 −0.016 0.009 5.78 × 10−1 0.187 −0.004 −0.018 0.010 5.43 × 10−1 0.205
Adiponectin (µg/mL) 0.006 −0.008 0.020 3.95 × 10−1 0.195 0.007 −0.008 0.021 3.69 × 10−1 0.216
PAI-I (ng/mL) 0.007 −0.017 0.031 5.61 × 10−1 0.188 0.008 −0.016 0.033 5.14 × 10−1 0.207
Resistin (ng/mL) −0.025 −0.056 0.006 1.19 × 10−1 0.197 −0.025 −0.057 0.007 1.24 × 10−1 0.214
TNF-α (pg/mL) −0.008 −0.035 0.019 5.55 × 10−1 0.202 −0.008 −0.036 0.019 5.55 × 10−1 0.219
IL-8 (pg/mL) −0.006 −0.023 0.010 4.50 × 10−1 0.254 −0.006 −0.022 0.011 5.26 × 10−1 0.278
IL-6 (pg/mL) −0.001 −0.017 0.015 8.93 × 10−1 0.187 −0.002 −0.018 0.015 8.19 × 10−1 0.205
Plasma biomarkers were log2 transformed. Model 1: Multiple linear regression adjusted for age (continuous, years), sex (male, females) and center (Granada, Gipuzkoa). Model 2:
Multiple linear regression adjusted age (continuous, years), sex (male, females) and center (Granada, Gipuzkoa), BMI (continuous, kg/m2), physical activity (inactive, moderately inactive
and active, active) and smoking status (never, former, current smoker). Statistically significant associations are shown in bold.
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Table 4. Association between P-NEAC as FRAP and the nutrient/inflammation biomarkers in the EPIC Granada–Gipuzkoa cohort sub-sample (n = 210).
Biomarkers
Model 1 Model 2
β Coefficient CI 95% p-Value R2 β Coeff CI 95% p-Value R2
Ascorbic Acid (µmol/L) 0.027 0.004 0.051 2.38 × 10−2 0.247 0.027 0.003 0.050 2.81 × 10−2 0.292
Dehydroascorbic acid (µmol/L) 0.001 0.000 0.001 1.73 × 10−1 0.235 0.001 0.000 0.001 1.64 × 10−1 0.281
Total vitamin C (µmol/L) 0.017 −0.004 0.038 1.07 × 10−1 0.238 0.017 −0.004 0.038 1.21 × 10−1 0.283
Retinol (µmol/L) 0.081 0.035 0.127 7.18 × 10−4 0.270 0.080 0.033 0.127 9.92 × 10−4 0.313
α-Tocopherol (µmol/L) 0.050 0.018 0.082 2.27 × 10−3 0.263 0.050 0.018 0.082 2.77 × 10−3 0.306
Carotenes (µmol/L) 0.017 0.001 0.033 3.78 × 10−2 0.244 0.017 0.001 0.034 3.76 × 10−2 0.290
Q9 (µmol/L) 0.013 −0.003 0.030 1.12 × 10−1 0.238 0.011 −0.005 0.028 1.90 × 10−1 0.280
Q10 (µmol/L) 0.062 0.033 0.091 4.13 × 10−5 0.289 0.062 0.032 0.092 6.43 × 10−5 0.331
Uric acid (mg/dl) 0.245 0.209 0.282 2.02 × 10−29 0.585 0.252 0.213 0.291 1.06 × 10−27 0.603
TRAP (µmol TE/L) 0.149 0.040 0.257 7.88 × 10−3 0.254 0.133 0.024 0.242 1.73 × 10−2 0.295
TEAC-ABTS (µmol TE/L) −0.015 −0.066 0.035 5.49 × 10−1 0.230 −0.018 −0.068 0.033 4.90 × 10−1 0.276
Total polyphenols (mg GAE/L) 0.262 0.119 0.406 4.20 × 10−4 0.274 0.246 0.095 0.397 1.65 × 10−3 0.310
ORAC without proteins (µmol TE/L) 0.033 −0.016 0.082 1.85 × 10−1 0.235 0.031 −0.019 0.079 2.24 × 10−1 0.280
ORAC (µmol TE/L) −0.037 −0.103 0.029 2.72 × 10−1 0.233 −0.043 −0.109 0.023 2.02 × 10−1 0.280
CRP (mg/L) 0.002 −0.013 0.016 8.37 × 10−1 0.229 −0.004 −0.019 0.012 6.44 × 10−1 0.277
Adiponectin (µg/mL) −0.005 −0.021 0.011 5.29 × 10−1 0.231 −0.002 −0.018 0.014 8.11 × 10−1 0.276
PAI-I (ng/mL) 0.019 −0.009 0.046 1.88 × 10−1 0.235 0.010 −0.018 0.039 4.68 × 10−1 0.276
Resistin (ng/mL) 0.011 −0.026 0.047 5.73 × 10−1 0.229 0.007 −0.030 0.043 7.24 × 10−1 0.275
TNF-α (pg/mL) 0.022 −0.009 0.053 1.68 × 10−1 0.207 0.016 −0.015 0.047 3.14 × 10−1 0.252
IL-8 (pg/mL) −0.003 −0.023 0.016 7.40 × 10−1 0.201 −0.008 −0.028 0.012 4.40 × 10−1 0.232
IL-6 (pg/mL) −0.016 −0.035 0.002 8.73 × 10−2 0.239 −0.016 −0.035 0.002 8.97 × 10−2 0.285
Plasma biomarkers were log2 transformed. Model 1: Multiple linear regression adjusted for age (continuous, years), sex (male, females) and center (Granada, Gipuzkoa). Model 2:
Multiple linear regression adjusted age (continuous, years), sex (male, females) and center (Granada, Gipuzkoa), BMI (continuous, kg/m2), physical activity (inactive, moderately inactive
and active, active) and smoking status (never, former, current smoker). Statistically significant associations are shown in bold.
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were found among either D-NEAC or P-NEAC assays with nutrient antioxidants, but not with 
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resulting of combinations of demographic and lifestyle factors according to levels of all biomarkers, 
suggest that there is variability of P-NEAC in relation to the antioxidant and inflammation status of 
each individual.  
4.1. D-NEAC and P-NEAC Relations 
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However, it has been argued that the in vitro antioxidant capacity may not reflect the real in vivo 
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Figure 2. Hierarchical clustering analysis of the analyzed biomarkers across the samples.
Unsupervised hierarchical clustering diagram for biomarker levels in 210 samples of the EPIC
Granada-Gipuzkoa study. S bjects (samples) were clustered into hierarchical t ees based on th levels of the
biomarkers, whic were clustered by their similarity (Manhattan dist nces). The clustering separated the
biomarkers and subjects into distinct groups. The joined clusters minimized the maximum within-cluster
distance. This value is the “height” at which the clusters merged, as indicated in the dendrogram,
with height represented on the y-axis. The lower the y-axis value, the lower distance between the clusters
and the stronger their relationship. Red indicates high biomarker levels and blue indicates low biomarker
levels. Missing data in certain biomarkers appears in white.
Several distinctive clusters were found in the hierarchical clustering (Figure 2). The dendrogram
showed that there were five clusters: two antioxidant’s cluster, the inflammation cluster and two NEAC
clusters. These clusters correlated with some characteristics of the subjects, giving rise to five clustered
patterns. Interestingly, subjects from Gipuzkoa and Granada were fit in separate clusters, while there were
two further clusters with a mixed pattern. In the first cluster, there were mainly women of EPIC-Granada
exhibiting NEAC and nutrient antioxidants levels below median values. The second cluster featured
an opposite pattern and comprised men and women from the EPIC-Gipuzkoa study. The third cluster
includ d subjects from both centers with P-NEAC levels higher than the average but varying levels of
vitamin C plasma levels. In the fourth cluster, while nutrient antioxidants levels were typically low,
P-NEAC levels were consistently high. In the fifth cluster, a remarkable feature was the relatively higher
ORAC and TEAC-ABTS levels compared to low levels of the FRAP and nutrient antioxidants. There was
no clear pattern of t e subject´s characteristics in hese clusters. Indeed, no differences in strata by smoking
status (Table S9), BMI (T ble S10), and other covariates, including physical activity (data not shown),
waist circumference (data not shown), season (data not shown) and adherence to the Mediterranean
diet (Table S11) were observed (p-value for interaction > 0.05). In general, non-defined patterns were
observed in these clusters for the inflammation-related biomarkers. NEAC and biomarker associations
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were examined in the largest cluster group (cluster-1). Within this cluster, there was no association
between the NEAC assays, but a significant association emerged between FRAP and uric acid (β = 0.22),
resistin (β = 0.08), CRP (β = 0.03) and adiponectin (β = –0.03) (Table S12).
In sensitivity analyses, we observed to some extent similar results after removing the biomarker´s
influential values on the associations (Table S13), and after discounting the contribution of uric acid to
the FRAP measure (Table S14).
4. Discussion
In this study we sought to examine the association between D-NEAC and P-NEAC with some
plasma antioxidants and inflammation markers. Overall, positive though moderate correlations were
found among either D-NEAC or P-NEAC assays with nutrient antioxidants, but not with inflammation
markers. These associations with nutrient antioxidants hold only for plasma FRAP in analyses adjusted
for age, sex, center, physical activity, BMI and smoking status. Clusters of subjects, resulting of
combinations of demographic and lifestyle factors according to levels of all biomarkers, suggest that
there is variability of P-NEAC in relation to the antioxidant and inflammation status of each individual.
4.1. D-NEAC and P-NEAC Relations
D-NEAC has been associated with health outcomes in several epidemiological studies [44]. However,
it has been argued that the in vitro antioxidant capacity may not reflect the real in vivo antioxidant
potential of the body [2,5,45]. Studies assessing the relationship between D-NEAC and P-NEAC have
reported, at best, moderately-weak correlations for some NEAC assays [4,14,15], while others did not
support a correlation [46]. Plasma FRAP, with and without uric acid was positively correlated with dietary
FRAP in our study. This result agrees with the study by Pellegrini et al., which reported a moderately-weak
correlation between dietary and plasma FRAP in an Italian study population of 285 healthy volunteers [15],
as well as with findings of a small study of 50 participants on NEAC diet-plasma relations that we
previously conducted [4]. The use of food frequency questionnaires (FFQ) to assess D-NEAC could be a
reason for this weak correlation since seasonal variations of antioxidant intakes are not well-captured.
However, we have previously shown that both FFQs and 24 h recalls similarly reflect the D-NEAC
and P-NEAC relationship [4]. Another possible reason for the seemingly weak correlation between
the two is that P-NEAC is affected by many lifestyle factors including dietary habits, the individual´s
physiological state, genetic variation and gut microbiome composition and function [47]. All of them
have a well-known direct impact on the mechanisms of digestion, absorption and metabolism of dietary
antioxidants, resulting in a high inter-individual variability of P-NEAC [45]. For instance, P-NEAC has
been found to be higher in smokers compared to non-smokers [5], in men [18] and in overweight/obese
individuals [12]. These studies had a small sample size and have not been replicated in other studies, or in
our study. Our results may be determined by this P-NEAC variability, as we did not observe an association
between dietary and plasma FRAP when accounting for lifestyle factors in multivariate regression models.
The somewhat weak correlations of D-NEAC and P-NEAC could also be due to the influence of other
antioxidant compounds in body fluids, such as proteins for ORAC and uric acid for FRAP [5]. In our study,
all associations were kept when removing their effect on the NEAC assays. The low bioavailability of some
antioxidants (e.g., flavonoids) only reach the nanomolar range in plasma [48], could also explain the low
correlation strength. Moreover, the majority of these NEAC assays are performed in aqueous solutions,
which implies that hydrophobic antioxidants or insoluble antioxidants can be underestimated [6].
4.2. Dietary/Plasma NEAC Associations with Nutrient/Inflammation Markers
In our study, there was no association between either D-NEAC and P-NEAC or CRP levels.
Likewise, no association was found between dietary FRAP and CRP levels among 532 healthy adults
participating in the ATTICA study [18], or among 4506 participants from the Rotterdam study [17].
ORAC plasma levels were also not associated with CRP levels in a study carried out among 815 Spanish
individuals [10]. The lack of an overall association in our study could be explained by the fact that levels
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of CRP fell within a low and narrow range. Indeed, our study population comprised healthy subjects
only, less likely to overproduce this marker. However, there are also studies reporting an association
between D-NEAC and CRP levels among healthy individuals, such as the study by Kobayashi et al.
that included 474 Japanese women [20], and the study by Brighenti et al. of 243 Italian non-diabetic
subjects [19]. Importantly, this latter study also showed that the association was higher for subjects with
hypertension than in normo-tensive individuals, suggesting that the association between D-NEAC and
plasma CRP may strengthen under pro-inflammatory conditions. Other previous studies have also
reported that a low intake of dietary antioxidants is associated with elevated inflammatory parameters,
supporting that inflammation may underpin mechanisms linking antioxidants and OS with disease
outcomes. The study by Wang et al., for instance, showed that a high D-NEAC intake was associated
with lower plasma CRP levels in 35 postmenopausal and overweight/obese women [12]. High P-NEAC
levels (FRAP) were also inversely associated with CRP levels among 80 patients with End-Stage Renal
Failure [9]. Thus, if antioxidants foods are related to a low inflammatory profile in low-grade chronic
inflammation conditions (e.g., smokers, obese and diseased individuals) and/or in a healthy state keeps
being an unresolved issue. Our study did also not support an association between NEAC and the
other inflammatory markers. With regard to studies that evaluated TNF-α, IL-6, PAI-I, resistin and
adiponectin in relation to D-NEAC or P-NEAC levels [9,11,12,17], only the Rotterdam study found
significant inverse associations between dietary FRAP and PAI-I and a positive association between
dietary FRAP and adiponectin [17].
With regard to nutrient antioxidant biomarkers, high P-NEAC as FRAP was associated with
high levels of almost all antioxidants, including TP. While this marker seems to not reflect the
amount of phenolic compounds contained in food [45], we observed positive associations between all
P-NEAC assays and TP. D-NEAC was also positively associated with dietary intake (all carotenoids
and flavonoids) and plasma antioxidant levels (lutein and α-tocopherol) in a study of 60 healthy
non-smoking subjects [3]. However, contrary to our study, higher NEAC levels (FRAP and VCEAC)
were not significantly related to increasing levels of ascorbic acid or TP in plasma. The study by
Wang et al. conducted among postmenopausal women also did not show significant associations
between D-NEAC/P-NEAC (ORAC, FRAP and VCEAC) and dietary intake of nutrient antioxidants [12].
Our study is therefore the first unravelling an association between both D-NEAC/P-NEAC and nutrient
antioxidant status.
While our results did not support different effect measures between D-NEAC/P-NEAC and the
biomarkers by sex, smoking status, obesity or physical activity (except center), there were distinctive
cluster groups of individuals. These clusters may reflect different patterns regarding the relationship
between P-NEAC and the nutrient and inflammation markers. Our study sample was too small
to observe differing association patterns across the subgroups or among individuals more prone to
inflammatory states, except within the largest cluster group. In this cluster, featuring non-smoking
and inactive women mainly, the trend went in the opposite direction for some inflammatory markers
(adiponectin, resistin and CRP).
One of the main limitations was we could not assess the association between D-NEAC and P-NEAC
with OS markers. Antioxidant enzymes playing a key role in the antioxidant defenses of the body
were also not considered. However, their impact on D-NEAC uptake is unclear. In fact, several studies
did not observe a significant change in their activity according to the intake of dietary antioxidants,
foods or supplements [49,50]. The degree of their activity depends on the individual´s genotype [51,52],
which may also have affected our results. Non-nutrient antioxidants not accounted for in this study
could have also influenced this association by activating pathways connected to the endogenous
defense and immune system [53]. We also had no measurements of other inflammatory markers
such as leptin, but to the best of our knowledge, this study has considered the largest set of markers.
Our results are therefore consistent with the absence of an association between an antioxidant-rich
diet and a low inflammatory state. However, we cannot fully rule out this association given the small
sample size. Other limitations are related to the study design (causal associations cannot be drawn),
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residual confounding (the influence of other covariates on the associations cannot be precluded),
generalizability of the results (their extrapolation to other populations cannot be established), and a
single biomarker assessment (variations of the associations over time cannot be assessed).
Regarding strengths, we used a DHQ administered by in-person interviews, and were able to
minimize measurement error in reporting the intake of anti-oxidant rich foods thanks to the fact
that information was collected on seasonal variations in the patterns of dietary intake, added fats,
recipes and dishes combining foods [23], among other issues. Measurement errors are also unlikely in
our biomarker determinations as all values fell in the expected range (e.g., BMI-adiponectin correlation;
rho = –0.63). Since there is a well-known variability of P-NEAC levels [45], we examined how lifestyle
and external factors could influence the associations. This is the first study demonstrating that there are,
indeed, many different profiles of subjects with varying relations between P-NEAC and the biomarkers.
Since coffee’s NEAC can confuse the total D-NEAC estimates [48,54], we considered both total D-NEAC
and D-NEAC without the contribution of coffee’s NEAC.
5. Conclusions
Findings from this study suggest that D-NEAC is related to P-NEAC to a weak extent.
Only P-NEAC, most likely FRAP, was positively associated with nutrient antioxidant levels in
plasma, whereas no association was observed with inflammation biomarkers. Thus, plasma FRAP
may best reflect the antioxidant potential of the human body but seem to not have anti-inflammatory
effects in healthy subjects. Our results also suggest that there may be subgroups of individuals with
low diet/plasma NEAC response against inflammation. The latter may comprise high-risk groups with
antioxidant depletion who are eligible for dietary/lifestyle interventions. Larger studies are warranted
to reexamine the existence of such groups and to validate these findings.
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